You are here: Home » Markets » News
Business Standard

Narayana Hrudayalaya surges 9%, hits record high in a range-bound market

Despite Covid-related challenges, the company posted substantial improvement in operational performance in September quarter

Narayana Hrudayalaya | Buzzing stocks | Markets

SI Reporter  |  Mumbai 

Covid-19 crisis: Health infra still a fight two months after lockdown
The stock of the healthcare services provider surpassed its previous high of Rs 389 touched on January 29, 2020

Shares of rallied by 9 per cent in the intra-day session and hit a record high of Rs 392 on the BSE on Friday in an otherwise range-bound market.

The stock of the healthcare services provider surpassed its previous high of Rs 389 touched on January 29, 2020. At 12:45 pm, the stock was trading 4 per cent higher at Rs 372 as compared to a 0.10 per cent-decline in the S&P BSE Sensex.

In July-September quarter (Q2FY21), had reported healthy operational performance sequentially with consolidated EBITDA (earnings before interest, taxes, depreciation, and amortization) of Rs 37.2 crore as against a loss of Rs 86.3 crore in Q1FY21. EBITDA margins, on the other hand, were at 4.5 per cent as against -23.1 per cent in Q1FY21 and 14.8 per cent in Q2FY20. Consolidated operating income grew 52.7 per cent to Rs 600.7 crore from Rs 393.5 crore in previous quarter.

The company's monthly consolidated revenue reached around 90 per cent of pre-Covid (Feb, 20) levels in the month of September, as per disclosure by the company. However, flagship facilities across Bengaluru and Kolkata continued to remain impacted given their pre-eminence in the cardiac sciences based elective domain as well as higher reliance on out-of-station domestic and international patients.

"However, units at Delhi-NCR and hinterland regions continue to demonstrate robust traction. The facility at Cayman Islands closed yet another quarter with the highest ever quarterly revenues," it said.

Notwithstanding a fresh wave of the pandemic, as is being witnessed across in certain parts of the world, the company expects to progress towards normalcy with improving sentiments, and expects a faster recovery as patients' mobility improves both at domestic and international fronts.

"Despite Covid-related challenges, the company posted substantial improvement in operational performance. Also, in September, the company's monthly consolidated revenues reached around 90 per cent of pre-covid (Feb' 20) levels. We continue to believe in the long term prospects of the company on the back of asset-right model and affordability philosophy," ICICI Securities had said in a recent note.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, November 20 2020. 13:02 IST